Evidence map›Paper›PMID 32839883›Full record

ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Neuronal intranuclear inclusion disease: two case report and literature review.

Xiang Qin, Hao Chen, Chenguang Zhou, XiaoLong Wang, Jingjing Gao, Nan Guo, Yujing Wang, Shaodong Li

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Clinicopathological features of neuronal intranuclear inclusion disease diagnosed by skin biopsy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  3. Review
  4. NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Review
  5. Neuronal intranuclear inclusion disease: recognition and update.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiang Qin *Radiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Hao Chen *Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Chenguang ZhouDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou university, Zhengzhou, Henan, China.
XiaoLong WangRadiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Jingjing GaoRadiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Nan GuoRadiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yujing WangDepartment of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Shaodong LiRadiology Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. qx19940211@163.com.ORCID http://orcid.org/0000-0003-4996-9691
Xuzhou Medical College · CNFifth Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal intranuclear inclusion disease (NIID) is a rare and slowly progressing neurodegenerative disease characterized by the presence of eosinophilic intranuclear inclusions in the nervous system and multiple visceral organs. Sporadic NIID case was more frequently encountered than familial. In our study, we reported two adult-onset NIID patients from a family and described their clinical, imaging, and pathological features. The first patient was a 61-year-old man who only presented with non-specific headache and dizziness; however, Brain MRI with diffusion-weighted images (DWI) sequence showed high-intensity signal involving a small regional portion of corticomedullary junction in the frontal and parietal lobe. The older sister of former, a 64-year-old female, who developed sudden onset of weakness of the right limb was admitted to our neurology department. Compared with the first patient, similar DWI high-intensity signal but more extensive area in the corticomedullary junction was found in her brain MRI examination, also prominent leukoencephalopathy in T2-weighted image. Significantly, skin pathology of the first patient showed that typical inclusions with strongly positive P62 and ubiquitin antibody could be seen in the nuclei of sweat gland cells, adipocytes, and fibroblasts. FMR1 gene was negative. Although rare, adult-onset NIID should be considered when the characteristic radiology changes of high intensity signal involving the corticomedullary junction in the brain DWI sequence was found. In addition, the pathological result of skin biopsy combined with negative genetic testing FMR1 or NOTCH2NLC can contribute to the accurate diagnosis of the disease. This article aims to improve the radiologists' knowledge of NIID by our cases presentation and reviewing literature.

Indexed as

Intranuclear Inclusion BodiesNeurodegenerative DiseasesAdultBiopsyFemaleFragile X Messenger Ribonucleoprotein 1HumansMagnetic Resonance ImagingMaleMiddle AgedFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Neuronal intranuclear inclusion disease

Identifiers

PMID32839883
OpenAlexW3080216061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.